Previous close | 3.1100 |
Open | 3.1100 |
Bid | 3.0500 x 1100 |
Ask | 3.0600 x 4000 |
Day's range | 3.0000 - 3.1220 |
52-week range | 2.5700 - 9.1200 |
Volume | |
Avg. volume | 2,118,253 |
Market cap | 1.13B |
Beta (5Y monthly) | 1.51 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.7250 |
Earnings date | 04 Aug 2022 - 08 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 4.84 |
TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) is pleased to announce the launch of the first of what is expected to be a range of products, in partnership with Geocann, which will utilize the advanced VESIsorb® delivery system. This technology provides better bioavailability and faster absorption. VESIsorb® formulations have set the industry benchmark in peer-reviewed published studies, delivering superior pharmacokinetic perf
TORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders held on June 23, 2022 (the “Meeting”) shareholders voting in person or by proxy held in total 265,763,587 common shares of the Company, representing 70.76% of the total number of common shares of the Company outstanding. Each of the directors listed as a nominee in the Company’s proxy statement dated April 29, 2022 (the “Proxy St
With the help of this approval, the crypto exchange company will be bringing its payment services within the Payment Services Act.